The Effect of Neoadjuvant Chemotherapy on Implant Loss in Immediate Tissue Expander-Based Breast Reconstruction.

Key Points

• The aim is to investigate the relationship between neoadjuvant chemotherapy and the risk of implant loss during breast reconstruction procedures.
• Analyzed the impact of neoadjuvant chemotherapy on tissue expander outcomes.
• Investigated various implant-related factors and chemotherapeutic agents as potential risks.
• Evaluated immediate tissue expander-based breast reconstruction procedures.
• Neoadjuvant chemotherapy is identified as an independent risk factor for tissue expander loss.
• Further analysis is required on specific chemotherapeutic agents and their influence on outcomes.